Nextage Therapeutics (XTAE:NXTG) Accounts Payable : ₪0.12 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Accounts Payable?

Nextage Therapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was ₪0.12 Mil.

Nextage Therapeutics's quarterly Accounts Payable declined from Dec. 2022 (₪0.14 Mil) to Jun. 2023 (₪0.06 Mil) but then increased from Jun. 2023 (₪0.06 Mil) to Dec. 2023 (₪0.12 Mil).

Nextage Therapeutics's annual Accounts Payable declined from Dec. 2021 (₪0.45 Mil) to Dec. 2022 (₪0.14 Mil) and declined from Dec. 2022 (₪0.14 Mil) to Dec. 2023 (₪0.12 Mil).

Nextage Therapeutics Accounts Payable Historical Data

The historical data trend for Nextage Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Accounts Payable Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.26

0.21

0.45

0.14

0.12

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial									0.45	0.13	0.14	0.06	0.12

Nextage Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Nextage Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021